<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The syndrome of <z:hpo ids='HP_0011010'>chronic</z:hpo> myelomonocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>) includes a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of patients who exhibit both myelodysplastic and myeloproliferative clinicopathological features </plain></SENT>
<SENT sid="1" pm="."><plain>Troublesome <z:hpo ids='HP_0001744'>splenomegaly</z:hpo> is uncommon in <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), but when organomegaly occurs, this complication is more likely to be associated with myelodysplastic-myeloproliferative <z:e sem="disease" ids="C0410000" disease_type="Disease or Syndrome" abbrv="">overlap syndromes</z:e> such as <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> rather than "<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-only" <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> types such as <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We report a single-institution experience with splenectomy in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> patients, including a detailed review of splenic histopathology </plain></SENT>
<SENT sid="3" pm="."><plain>Twelve patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> underwent splenectomy at the Mayo Clinic, primarily because of refractory <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and/or mechanical complications related to <z:hpo ids='HP_0001744'>splenomegaly</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Three of the 12 patients (25%) died as a direct result of surgery, and significant postoperative morbidity was seen in another 4 patients (33%) </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001873'>Thrombocytopenia</z:hpo> improved in 4 of the 11 patients (36%) with <z:hpo ids='HP_0001873'>low platelet counts</z:hpo> before surgery </plain></SENT>
<SENT sid="6" pm="."><plain>Three of the four responders had an abundance of CD68 (PGM1)-positive foamy histiocytes in the marginal zone surrounding the splenic white pulp-a pattern which can be seen in <z:hpo ids='HP_0001973'>immune thrombocytopenia</z:hpo>-and two of these three patients had <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> out of proportion to the degree of <z:hpo ids='HP_0001903'>anemia</z:hpo> pre-operatively, suggestive of peripheral destruction of platelets </plain></SENT>
<SENT sid="7" pm="."><plain>More consistent splenic pathological findings in the 12 patients included trilineage <z:hpo ids='HP_0001978'>extramedullary hematopoiesis</z:hpo> in splenic red pulp and expansion of splenic cords by a myelomonocytic infiltrate </plain></SENT>
<SENT sid="8" pm="."><plain>This study underscores both the uniformity and diversity of splenic findings in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e>, highlights the potential dangers and benefits of splenectomy in this group, and suggests peripheral destruction of platelets as a mechanism contributing to <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> in a subset of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CMML</z:e> patients </plain></SENT>
</text></document>